Darwin Cell

达尔文生物

Darwin Cell

Biotech/Healthcare

Beijing Darwin Cell Biotechnology is a national high-tech enterprise with 10 years of experience in the clinical translation of stem-cell technologies. In the second half of 2021, it achieved breakthrough validation in clinical translation and secured multiple core patents in China and overseas.

Latest round: Series C (2025)

Source: ChinaBulls — chinabulls.com

Last updated 2025-07-01